Long-term Prognosis of Children With Bronchiectasis Treated With Low-dose Erythromycin Intervention
Condition(s):BronchiectasisLast Updated:August 28, 2019Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):BronchiectasisLast Updated:August 28, 2019Not yet recruiting
Condition(s):Preterm Premature Ruptured MembranesLast Updated:March 5, 2014Withdrawn
Condition(s):FAP-Familial Adenomatous PolyposisLast Updated:June 26, 2014Unknown status
Condition(s):FAP-Familial Adenomatous PolyposisLast Updated:February 3, 2015Unknown status
Condition(s):Epidermolysis BullosaLast Updated:October 14, 2011Unknown status
Condition(s):Parkinson’s Disease; LevodopaLast Updated:February 3, 2017Completed
Condition(s):GastroparesisLast Updated:December 5, 2014Terminated
Condition(s):HealthyLast Updated:January 19, 2021Recruiting
Condition(s):Variceal BleedingLast Updated:February 2, 2010Completed
Condition(s):Preterm Premature Rupture of Membranes (PPROM)Last Updated:January 7, 2021Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.